Cellworks myCare™ Clinical Trial Transforms NGS Data into Personalized Cancer Therapy Actions
New Trial Biosimulates Efficacy of Cancer Therapies Using Molecular Genetic Aberration Data…
Cellworks Study Predicted Non-Response to Azacitidine in MDS Patients with 100% Accuracy using AI-Driven Biosimulation
Analysis Uncovered Possible Mechanisms for AZA Resistance that could be Targeted to Induce…
Cellworks AI-Driven Biosimulation Predicted Chemo-resistance in AML and MDS Patients with 90% Accuracy
Prospective Study Successfully Identified Mechanisms for AML…
Cellworks to Present 10 Abstracts at 2018 American Society of Hematology Annual Meeting
ASH Abstracts Reveal How AI-Driven Biosimulation Technology Predicts Drug Response in Individual…